Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2

The Oncofetal Protein IMP3

(2009) Wenxin Zheng et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

An Oncofetal Protein IMP3

(2009) Di Lu et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Diffuse Expression of RNA-Binding Protein IMP3 Predicts High-Stage Lymph Node Metastasis and Poor Prognosis in Colorectal Adenocarcinoma

(2009) Ray-Hwang Yuan et al.   ANNALS OF SURGICAL ONCOLOGY

IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis

(2009) Dawei Li et al.   ANNALS OF SURGICAL ONCOLOGY

Insulin-Like Growth Factor mRNA Binding Protein 3 (IMP3) is Differentially Expressed in Benign and Malignant Follicular Patterned Thyroid Tumors

(2009) Magdalena Slosar et al.   ENDOCRINE PATHOLOGY

IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype

(2009) Otto Walter et al.   HUMAN PATHOLOGY

IMP3 expression in non–small cell lung cancer

(2009) Guido Bellezza et al.   HUMAN PATHOLOGY

IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas

(2009) Marc-Oliver Riener et al.   HUMAN PATHOLOGY

IMP3 Expression in Human Ovarian Cancer is Associated With Improved Survival

(2009) Aurelia Noske et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype

(2009) Martin Köbel et al.   MODERN PATHOLOGY

Development of a novel mouse glioma model using lentiviral vectors

(2009) Tomotoshi Marumoto et al.   NATURE MEDICINE

External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma

(2008) Nathan E. Hoffmann et al.   CANCER

Oncofetal protein IMP3

(2008) Zhong Jiang et al.   CANCER

IMP3 Predicts Aggressive Superficial Urothelial Carcinoma of the Bladder

(2008) L. Sitnikova et al.   CLINICAL CANCER RESEARCH

IMP3: A New and Important Biomarker of Systemic Malignancies

(2008) S. Kapoor   CLINICAL CANCER RESEARCH

Combination of Quantitative IMP3 and Tumor Stage: A New System to Predict Metastasis for Patients with Localized Renal Cell Carcinomas

(2008) Z. Jiang et al.   CLINICAL CANCER RESEARCH

IMP3: a diagnostic and prognostic biomarker in malignant melanoma

(2008) Haodong Xu   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors

(2008) Lin Li et al.   HUMAN PATHOLOGY

Malignant Gliomas in Adults

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Malignant Gliomas in Adults

(2008) Patrick Y. Wen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Expression of Insulin-Like Growth Factor-II mRNA Binding Protein 3 (IMP3) in Osteosarcoma

(2008) Sung-Im Do et al.   ONCOLOGY RESEARCH

The role of insulin receptors and IGF-I receptors in cancer and other diseases

(2008) Francesco Frasca et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY